Phoenix Bioinformatics Corporation

“The form 990 will be reviewed by the board of directors prior to submission.”

“A conflict of interest policy was adopted by the board in 2015 and applied beginning in 2016. The conflict of interest policy applies to all directors, officers and staff, who are each asked to review, complete and submit a coi form annually. The completed forms are reviewed for conflicts by the executive director. If a conflict or potential conflict is reported, the board of directors is informed and appropriate action is decided by vote of the board, with the person with the potential conflct abstaining from the discussion and vote. The secretary will maintain a list of conflicted entities and individuals. The executive director will match proposed transactions against the list to identify such transactions, prohibit any conflicted person from participating in the discussion of or decision to proceed with such a transaction, and submit the transaction for a vote of the board minus any conflicted parties to determine whether the transaction is in the interest of phoenix bioinformatics. No conflicts were identified in 2017 or 2018.”

“The compensation review was completed at the end of 2018. The review included the compensation of both the executive director and the chief financial officer (cfo). External sources were used to assess the appropriate level of compensation for these positions in other comparable organizations. The independent directors approved the comparability data and compensation of both officers. The compensation review and approval process is the same for officers and key employees. The compensation review and approval process is the same for officers and key employees.”

“The organization makes its governing documents, conflict of interest policy and financial statements available to the public on the organization's website.”